RxDoctor Payments DataLook up a doctor →

Vivian Laquer, MD

Dermatology · Irvine, CANPI 1164656229

Payments from drug & device makers

$20,890,341in general payments, 2019–2025

Across 3,937 payments — averaging $5306.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Eli Lilly$4.1M
  • Amgen$2.2M
  • Incyte Corporation$2.1M
  • Takeda Pharmaceuticals U.S.A., Inc.$1.6M
  • AbbVie$1.6M
  • Janssen Research & Development, LLC$1.4M
  • plus $7.8M from 49 others
$247,290in research payments, 2019–2025

Across 31 payments — averaging $7977.08 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Bausch Health US, LLC$131K
  • Eli Lilly$114K
  • Novartis$2K
  • Biofrontera Inc.$78

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Eli Lilly210$4,060,418
Amgen(2 entities)150$2,234,089
Incyte Corporation902$2,084,066
Takeda Pharmaceuticals U.S.A., Inc.113$1,643,443
AbbVie494$1,586,985
Janssen Research & Development, LLC196$1,433,063
Pfizer(2 entities)323$1,058,626
Novartis146$1,037,053
Sanofi US Services Inc.115$974,224
LEO Pharma AS83$889,262
UCB SA49$637,642
Sun Pharmaceutical Industries Inc.318$606,886
E.r. Squibb & Sons, L.L.C.36$524,965
Bausch Health US, LLC5$232,061
Biofrontera Inc.10$211,802
Bristol Myers Squibb18$180,954
Galderma Laboratories, L.p.45$175,169
Regeneron31$157,455
Biofrontera Bioscience GmbH10$152,515
Boehringer Ingelheim18$146,001
Argenx US, Inc.31$117,737
GSK33$108,893
Aclaris Therapeutics, Inc.7$88,762
Dermavant Sciences, Inc.195$83,564
Acrotech Biopharma Inc.9$78,615
Dermira, Inc.12$69,400
Dr.reddy's Laboratories,inc.23$68,144
Galderma Research & Development, LLC4$57,520
Arcutis Biotherapeutics, Inc.23$51,887
Kiniksa Pharmaceuticals International, PLC3$42,214
Kiniksa Pharmaceuticals, Ltd.29$28,166
Genentech, Inc.5$18,329
UCB, Inc.53$13,900
Biogen3$9,365
Sanofi16$7,635
LEO Pharma Inc.37$4,674
UCB Biosciences Inc.36$3,415
Boehringer Ingelheim International GmbH3$3,269
Organon2$2,467
Lilly USA, LLC51$1,438
Almirall LLC6$944
Johnson & Johnson20$741
Janssen Scientific Affairs, LLC10$606
Ortho Dermatologics, A Division Of Bausch Health US, LLC15$513
Regeneron Healthcare Solutions, Inc.15$456
Sanofi-aventis U.S. LLC5$364
Avita Medical Americas, LLC2$276
Mayne Pharma Commercial LLC6$100
EPI Health, LLC2$97
Merck3$59
VYNE Pharmaceuticals Inc.2$58
Journey Medical Corporation1$18
Encore Dermatology Inc.1$15
Medimetriks Pharmaceuticals, Inc.1$12
Prugen, Inc. Pharmaceuticals1$11

How this compares

$20,890,341 in reported general payments places this provider in the 95th percentile of 1,875 dermatology providers in California.

See all dermatology providers in California →

Medicare billing

Part B allowed, 2024
$115,223
Medicare patients
70
Services billed
696

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other dermatology in Irvine

See the full list for California →

Where these figures come from

Is this you, or does something look wrong? →